title: Effect of traditional chinese medicine on survival and quality of life in patients with esophageal carcinoma after esophagectomy.
abstract: OBJECTIVE
  To explore the effect and possible mechanism of traditional Chinese medicine (TCM) on survival and quality of life (QOL) in patients with esophageal carcinoma after esophagectomy.
  
  
  METHODS
  Adopting prospective controlled method of study, the authors had 128 post-esophagectomy patients, hospitalized from February 2001 to February 2002, randomly divided into 3 groups: the TCM group, treated with TCM drugs alone; the chemotherapy group, with chemotherapy alone applied; and the synthetic group, treated with chemotherapy combined with Chinese medicine. Their survival rate and QOL were compared.
  
  
  RESULTS
  In the TCM group, the chemotherapy group and the synthetic group, the respective 3-year relapse and remote metastasis rate were 71.4%, 76.7%, 53.4%, respectively (chi(2) = 6.53, P < 0.05); the 1-year survival rate 42.9%, 46.5%, 72.1%; 2-year survival rate 28.6%, 27.9%, 55.8%, and 3-year survival rate 26.2%, 23.1%, 37.2%, respectively. And the QOL improving rate was 69.0%, 37.2%, 58.1%, respectively, all showing significant difference among them (chi(2) = 6.10, all P < 0.05). Moreover, immune function was increased in the TCM and the synthetic groups.
  
  
  CONCLUSIONS
  Integrative Chinese and Western medicinal treatment was the beneficial choice for post-operational patients with esophageal carcinoma. However, long time use of simple Chinese medicine was also advisable, especially for those in poverty.
authors.affiliation: Oncology Department, the First Affiliated Hospital of Xinxiang Medical College, Weihui, Henan, China. luping114@sohu.com
authors.forename: Ping
authors.initials: P
authors.lastname: Lu
authors.forename: Qiu-dong
authors.initials: QD
authors.lastname: Liang
authors.forename: Rong
authors.initials: R
authors.lastname: Li
authors.forename: Hong-rui
authors.initials: HR
authors.lastname: Niu
authors.forename: Xiao-ge
authors.initials: XG
authors.lastname: Kou
authors.forename: Hong-jun
authors.initials: HJ
authors.lastname: Xi
mesh_terms: D000328:Adult; D000368:Aged; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000009:adverse effects; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D016629:Esophagectomy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007107:Immune System / Q000187:drug effects; D007136:Immunoglobulins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality; D011446:Prospective Studies; D011788:Quality of Life; D015996:Survival Rate; D016176:T-Lymphocyte Subsets
chemical_list: D004365:Drugs, Chinese Herbal; D007136:Immunoglobulins